Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity
Related Posts
Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]
Lari SM, Liang H, Dadfar B, Zhou J, Kim J, Sayah D, Der Hovanessian A, Saggar R, Shino MY, Turner G, Amubieya O, Haddad T,[...]
Echocardiographic estimates of pulmonary artery acceleration time and mortality risk in older adults
Nations JA, Mordini FE, Khosla R, Lam PH, Frishman WH, Aronow WS, Bytyçi I, Böhm M, Aldabain L, Vyas K, Mashaal H, Zhang S, Morgan[...]